By Linda Young, January 8, 2007 (All Headline News)- A breakthrough in producing stem cells for research from amniotic fluid rather than aborted fetuses might be good news for people suffering from disease, including Parkinson's and Alzheimer's. That new source of stem cells for research could lead to more research being done.
Currently such research is limited by law because of the controversy over the source of stem cells...
January 5, 2007 (DrugNewswire)- Boston Life Sciences, Inc. (NASDAQ:BLSI) , a biotechnology company focused on diagnostic and therapeutic products for central nervous system disorders, announced today that it has entered into an exclusive, worldwide license with BioAxone Therapeutic Inc. of Montreal, Canada, to develop and commercialize Cethrin as well as other specified compounds subject to the license to treat acute spinal cord injury (SCI) and other serious central nervous system disorders. The license provides for an up-front license fee, possible performance milestones, and on-going royalties based on sales of Cethrin after approval...
January 3, 2007 (EurekAlert!)- Uric acid is commonly associated with the excruciatingly painful joint disease known as gout, but it can also play a crucial role in the treatment of spinal cord injury and other central nervous system disorders, such as stroke, multiple sclerosis and Parkinson's disease, according to Rutgers' Bonnie Firestein.
Firestein, an associate professor of cell biology and neuroscience at Rutgers, The State University of New Jersey, and her laboratory team have reported their discovery in the Early View (online in advance of print) version of the journal Glia...